To summarize, enteral bovine or recombinant human lactoferrin resulted in a possibly slightly lower incidence of late-onset sepsis (studied in 5425 infants in total), but no effects were observed on NEC, mortality, or neurodevelopment [11]. This evidence concerns the gene LTF and necrotizing enterocolitis.